Biotage AB (publ) (STO: BIOT)
Sweden
· Delayed Price · Currency is SEK
197.20
+2.50 (1.28%)
Aug 30, 2024, 5:29 PM CET
Biotage AB Revenue
Biotage AB had revenue of 504.00M SEK in the quarter ending June 30, 2024, with 23.23% growth. This brings the company's revenue in the last twelve months to 2.08B, up 33.66% year-over-year. In the year 2023, Biotage AB had annual revenue of 1.86B with 18.90% growth.
Revenue (ttm)
2.08B
Revenue Growth
+33.66%
P/S Ratio
7.60
Revenue / Employee
3.11M
Employees
674
Market Cap
15.79B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.86B | 296.00M | 18.90% |
Dec 31, 2022 | 1.57B | 334.00M | 27.11% |
Dec 31, 2021 | 1.23B | 140.00M | 12.82% |
Dec 31, 2020 | 1.09B | -9.37M | -0.85% |
Dec 31, 2019 | 1.10B | 190.48M | 20.91% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
Swedish Orphan Biovitrum AB (publ) | 23.71B |
Getinge AB (publ) | 33.33B |
Sectra AB (publ) | 3.04B |
Camurus AB (publ) | 1.59B |
Vitrolife AB (publ) | 3.54B |
Medicover AB (publ) | 21.70B |
Elekta AB (publ) | 18.12B |